Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Historically, clinical trials and medical research operated separately from the routine care provided in local healthcare facilities and by individual doctors. Many physicians remained unaware of ongoing research initiatives, leaving patients largely uninformed about studies that could enhance their treatment outcomes or health. Elligo has transformed this landscape by facilitating unprecedented participation in clinical research through access to a vast network of over 150 million patients and their comprehensive data, enabling doctors to present research opportunities to patients who might not otherwise encounter them. Traditional methods of recruiting participants often face challenges, such as the need for patients to travel to specific research sites, which can limit involvement. Moreover, studies indicate that patients are more inclined to participate in research when it is associated with their trusted healthcare provider, underscoring the importance of integrating clinical research into familiar medical environments. This approach not only bridges the gap between research and patient care but also empowers individuals to take part in potentially life-changing medical advancements.
Description
Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Elligo Health Research
Country
United States
Website
www.elligohealthresearch.com
Vendor Details
Company Name
Unlearn
Country
United States
Website
www.unlearn.ai/
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning